East Carolina University Vidant Cancer Care
Eddie and Jo Allison Smith Tower
Greenville, NC
Accepting patients
MagnetisMM-32
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- Bispecific Antibody
- BCMA
- Randomization
- Phase 3
Accepting patients
Registry of Older Patients With Cancer
Carolina Senior: UNC Registry for Older Cancer Patients
- Patient Registry
- Observational Trial
Not currently accepting
EQUATE
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Monoclonal Antibody
- CD38
- Phase 3
Not yet accepting
MajesTEC-4
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4
- Bispecific T Cell Engager (BiTE)
- Bispecific Antibody
- BCMA
- Phase 3
Accepting patients
Early Detection Blood Tests
Blinded Reference Set for Multicancer Early Detection Blood Tests
- Observational Trial
1 hidden based on your filters.Show All